Drug Intelligence

Real-World Evidence (RWE) Data Experts In: Specialty medical treatment databases Detailed market metric reports Retrospective & prospective health outcomes studies Health resource economics studies Prospective health registries Drug Intelligence collects, analyzes & interprets how complex drug treatments are used in the real world, in real-time to inform pharmaceutical industry, physicians, payers and pharmacists. We achieve this by defining and bridging therapeutic data gaps, leveraging meaningful RWE to address treatment adoption, market challenges and secure payer access. What makes DI unique? • The holistic approach: rather than looking any one data point or drug in isolation, we provide meaningful analytics by evaluating the full picture of the disease state and therapeutic use • Proprietary real world, real-time disease treatment databases spanning 20+ years in hospital, specialty clinic and office settings that offer detailed market analytics of drug therapy • Contract Research Organization (CRO) for real-world evidence studies in health outcomes and health resource use (retrospective/prospective data research and health registries) • Clinical and commercial expertise in multiple therapeutic areas • Bilingual (English, French)